AAAAAA

   
Results: 1-19 |
Results: 19
THE SELECTIVE DOPAMINE D1 RECEPTOR AGONIST A-86929 MAINTAINS EFFICACYWITH REPEATED TREATMENT IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE
Authors: ASIN KE DOMINO EF NIKKEL A SHIOSAKI K
Citation: Ke. Asin et al., THE SELECTIVE DOPAMINE D1 RECEPTOR AGONIST A-86929 MAINTAINS EFFICACYWITH REPEATED TREATMENT IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 454-459
SUBSTITUTED HEXAHYDROBENZO[F]THIENO[C]QUINOLINES AS DOPAMINE D1-SELECTIVE AGONISTS - SYNTHESIS AND BIOLOGICAL EVALUATION IN-VITRO AND IN-VIVO
Authors: MICHAELIDES MR HONG YF DIDOMENICO S BAYBURT EK ASIN KE BRITTON DR LIN CW SHIOSAKI K
Citation: Mr. Michaelides et al., SUBSTITUTED HEXAHYDROBENZO[F]THIENO[C]QUINOLINES AS DOPAMINE D1-SELECTIVE AGONISTS - SYNTHESIS AND BIOLOGICAL EVALUATION IN-VITRO AND IN-VIVO, Journal of medicinal chemistry, 40(11), 1997, pp. 1585-1599
COMPARTMENTALLY SPECIFIC EFFECTS OF QUINPIROLE ON THE STRIATAL FOS EXPRESSION INDUCED BY STIMULATION OF D-1-DOPAMINE RECEPTORS IN INTACT RATS
Authors: WIRTSHAFTER D SCHARDT G ASIN KE
Citation: D. Wirtshafter et al., COMPARTMENTALLY SPECIFIC EFFECTS OF QUINPIROLE ON THE STRIATAL FOS EXPRESSION INDUCED BY STIMULATION OF D-1-DOPAMINE RECEPTORS IN INTACT RATS, Brain research, 771(2), 1997, pp. 271-277
PERSISTENT ACTIVATION OF THE DOPAMINE D-1 RECEPTOR CONTRIBUTES TO PROLONGED RECEPTOR DESENSITIZATION - STUDIES WITH A-77636
Authors: LIN CW BIANCHI BR MILLER TR STASHKO MA WANG SS CURZON P BEDNARZ L ASIN KE BRITTON DR
Citation: Cw. Lin et al., PERSISTENT ACTIVATION OF THE DOPAMINE D-1 RECEPTOR CONTRIBUTES TO PROLONGED RECEPTOR DESENSITIZATION - STUDIES WITH A-77636, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 1022-1029
ABT-431 - THE DIACETYL PRODRUG OF A-86929, A POTENT AND SELECTIVE DOPAMINE D-1 RECEPTOR AGONIST - IN-VITRO CHARACTERIZATION AND EFFECTS IN ANIMAL-MODELS OF PARKINSONS-DISEASE
Authors: SHIOSAKI K JENNER P ASIN KE BRITTON DR LIN CW MICHAELIDES M SMITH L BIANCHI B DIDOMENICO S HODGES L HONG YF MAHAN L MIKUSA J MILLER T NIKKEL A STASHKO M WITTE D WILLIAMS M
Citation: K. Shiosaki et al., ABT-431 - THE DIACETYL PRODRUG OF A-86929, A POTENT AND SELECTIVE DOPAMINE D-1 RECEPTOR AGONIST - IN-VITRO CHARACTERIZATION AND EFFECTS IN ANIMAL-MODELS OF PARKINSONS-DISEASE, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 150-160
HYPERACTIVITY AND BEHAVIORAL SEIZURES IN RODENTS FOLLOWING TREATMENT WITH THE DOPAMINE D-1 RECEPTOR AGONISTS A-86929 AND ABT-431
Authors: SHIOSAKI K ASIN KE BRITTON DR GIARDINA WJ BEDNARZ L MAHAN L MIKUSA J NIKKEL A WISMER C
Citation: K. Shiosaki et al., HYPERACTIVITY AND BEHAVIORAL SEIZURES IN RODENTS FOLLOWING TREATMENT WITH THE DOPAMINE D-1 RECEPTOR AGONISTS A-86929 AND ABT-431, European journal of pharmacology, 317(2-3), 1996, pp. 183-190
MK-801 DIFFERENTIALLY AFFECTS DOPAMINE D1 AND D2 RECEPTOR AGONIST-INDUCED BEHAVIORAL TOLERANCE AND DESENSITIZATION
Authors: ASIN KE BEDNARZ L NIKKEL AL
Citation: Ke. Asin et al., MK-801 DIFFERENTIALLY AFFECTS DOPAMINE D1 AND D2 RECEPTOR AGONIST-INDUCED BEHAVIORAL TOLERANCE AND DESENSITIZATION, Brain research, 725(1), 1996, pp. 67-74
A-86929 - A SELECTIVE DOPAMINE D1 RECEPTOR AGONIST EFFICACIOUS IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE
Authors: ASIN KE NIKKEL A BEDNARZ L DOMINO EF SHIOSAKI K
Citation: Ke. Asin et al., A-86929 - A SELECTIVE DOPAMINE D1 RECEPTOR AGONIST EFFICACIOUS IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE, The FASEB journal, 9(3), 1995, pp. 395-395
ROTATION AND STRIATAL C-FOS EXPRESSION AFTER REPEATED, DAILY TREATMENT WITH SELECTIVE DOPAMINE-RECEPTOR AGONISTS AND LEVODOPA
Authors: ASIN KE BEDNARZ L NIKKEL A PERNER R
Citation: Ke. Asin et al., ROTATION AND STRIATAL C-FOS EXPRESSION AFTER REPEATED, DAILY TREATMENT WITH SELECTIVE DOPAMINE-RECEPTOR AGONISTS AND LEVODOPA, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1483-1490
HIA-5-AZACYCLOPENT-1-ENA[C]-PHENANTHRENE-9,10-DIOL (A-86929) - A POTENT AND SELECTIVE DOPAMINE D1 AGONIST THAT MAINTAINS BEHAVIORAL EFFICACY FOLLOWING REPEATED ADMINISTRATION AND CHARACTERIZATION OF ITS DIACETYL PRODRUG (ABT-431)
Authors: MICHAELIDES MR HONG YF DIDOMENICO S ASIN KE BRITTON DR LIN CW WILLIAMS M SHIOSAKI K
Citation: Mr. Michaelides et al., HIA-5-AZACYCLOPENT-1-ENA[C]-PHENANTHRENE-9,10-DIOL (A-86929) - A POTENT AND SELECTIVE DOPAMINE D1 AGONIST THAT MAINTAINS BEHAVIORAL EFFICACY FOLLOWING REPEATED ADMINISTRATION AND CHARACTERIZATION OF ITS DIACETYL PRODRUG (ABT-431), Journal of medicinal chemistry, 38(18), 1995, pp. 3445-3447
DOPAMINE ANTAGONISTS INDUCE FOS-LIKE-IMMUNOREACTIVITY IN THE SUBSTANTIA-NIGRA AND ENTOPEDUNCULAR NUCLEUS OF THE RAT
Authors: WIRTSHAFTER D ASIN KE
Citation: D. Wirtshafter et Ke. Asin, DOPAMINE ANTAGONISTS INDUCE FOS-LIKE-IMMUNOREACTIVITY IN THE SUBSTANTIA-NIGRA AND ENTOPEDUNCULAR NUCLEUS OF THE RAT, Brain research, 670(2), 1995, pp. 205-214
INTERACTIVE EFFECTS OF STIMULATION OF D-1 AND D-2 DOPAMINE-RECEPTORS ON FOS-LIKE IMMUNOREACTIVITY IN THE NORMOSENSITIVE RAT STRIATUM
Authors: WIRTSHAFTER D ASIN KE
Citation: D. Wirtshafter et Ke. Asin, INTERACTIVE EFFECTS OF STIMULATION OF D-1 AND D-2 DOPAMINE-RECEPTORS ON FOS-LIKE IMMUNOREACTIVITY IN THE NORMOSENSITIVE RAT STRIATUM, Brain research bulletin, 35(1), 1994, pp. 85-91
TETRAPEPTIDE CCK-A AGONISTS - EFFECT OF BACKBONE N-METHYLATIONS ON IN-VITRO AND IN-VIVO CCK ACTIVITY
Authors: HOLLADAY MW KOPECKA H MILLER TR BEDNARZ L NIKKEL AL BIANCHI BR WITTE DG SHIOSAKI K LIN CW ASIN KE NADZAN AM
Citation: Mw. Holladay et al., TETRAPEPTIDE CCK-A AGONISTS - EFFECT OF BACKBONE N-METHYLATIONS ON IN-VITRO AND IN-VIVO CCK ACTIVITY, Journal of medicinal chemistry, 37(5), 1994, pp. 630-635
TETRAPEPTIDE CCK AGONISTS - STRUCTURE-ACTIVITY STUDIES ON MODIFICATIONS AT THE N-TERMINUS
Authors: ELLIOTT RL KOPECKA H BENNETT MJ SHUE YK CRAIG R LIN CW BIANCHI BR MILLER TR WITTE DG STASHKO MA ASIN KE NIKKEL A BEDNARZ L NADZAN AM
Citation: Rl. Elliott et al., TETRAPEPTIDE CCK AGONISTS - STRUCTURE-ACTIVITY STUDIES ON MODIFICATIONS AT THE N-TERMINUS, Journal of medicinal chemistry, 37(2), 1994, pp. 309-313
NOVEL ASP(32)-REPLACEMENT TETRAPEPTIDE ANALOGS AS POTENT AND SELECTIVE CCK-A AGONISTS
Authors: ELLIOTT RL KOPECKA H TUFANO MD SHUE YK GAURI AJ LIN CW BIANCHI BR MILLER TR WITTE DG STASHKO MA ASIN KE NIKKEL AL BEDNARZ L NADZAN AM
Citation: Rl. Elliott et al., NOVEL ASP(32)-REPLACEMENT TETRAPEPTIDE ANALOGS AS POTENT AND SELECTIVE CCK-A AGONISTS, Journal of medicinal chemistry, 37(11), 1994, pp. 1562-1568
CCK-A-SELECTIVE TETRAPEPTIDES CONTAINING LYS(N-E)-AMIDE RESIDUES - FAVORABLE IN-VIVO AND IN-VITRO EFFECTS OF N-METHYLATION AT THE ASPARTYL RESIDUE
Authors: BENNETT MJ NIKKEL AL BIANCHI BR MILLER TR BEDNARZ L WITTE DG STASHKO M WANG SS GORE PA ASIN KE LIN CW NADZAN AM HOLLADAY MW
Citation: Mj. Bennett et al., CCK-A-SELECTIVE TETRAPEPTIDES CONTAINING LYS(N-E)-AMIDE RESIDUES - FAVORABLE IN-VIVO AND IN-VITRO EFFECTS OF N-METHYLATION AT THE ASPARTYL RESIDUE, Journal of medicinal chemistry, 37(11), 1994, pp. 1569-1571
REPEATED D-1 RECEPTOR AGONIST TREATMENT BLOCKS COCAINE-INDUCED LOCOMOTOR-ACTIVITY AND C-FOS EXPRESSION
Authors: ASIN KE NIKKEL AL WIRTSHAFTER D
Citation: Ke. Asin et al., REPEATED D-1 RECEPTOR AGONIST TREATMENT BLOCKS COCAINE-INDUCED LOCOMOTOR-ACTIVITY AND C-FOS EXPRESSION, Brain research, 637(1-2), 1994, pp. 342-344
DOPAMINE AGONISTS AND STRESS PRODUCE DIFFERENT PATTERNS OF FOS-LIKE IMMUNOREACTIVITY IN THE LATERAL HABENULA
Authors: WIRTSHAFTER D ASIN KE PITZER MR
Citation: D. Wirtshafter et al., DOPAMINE AGONISTS AND STRESS PRODUCE DIFFERENT PATTERNS OF FOS-LIKE IMMUNOREACTIVITY IN THE LATERAL HABENULA, Brain research, 633(1-2), 1994, pp. 21-26
EFFECTS OF REPEATED DOPAMINE-D(1) RECEPTOR STIMULATION ON ROTATION AND C-FOS EXPRESSION
Authors: ASIN KE WIRTSHAFTER D
Citation: Ke. Asin et D. Wirtshafter, EFFECTS OF REPEATED DOPAMINE-D(1) RECEPTOR STIMULATION ON ROTATION AND C-FOS EXPRESSION, European journal of pharmacology, 235(1), 1993, pp. 167-168
Risultati: 1-19 |